Trials / Sponsors / Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | RBN-2397 in Combination With Pembrolizumab in Patients With SCCL Advanced Squamous Non-Small Cell Lung Carcinoma | Phase 1 / Phase 2 | 2022-03-15 |
| Unknown | SAD/MAD Safety and PK Study of RBN-3143 in Healthy and Atopic Dermatitis Subjects Atopic Dermatitis | Phase 1 | 2022-03-07 |
| Unknown | Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors Solid Tumor, Adult | Phase 1 | 2019-08-01 |